A consultant physician of the most discerning standard — offering private gastroenterology and hepatologic care to a select clientele on two coasts.
Dr. Amit H. Sachdev is a double board-certified specialist in gastroenterology and hepatology whose practice and research have taken him from the operating theatres of New York to the policy corridors of the West Wing. He completed his medical training at the country's most distinguished institutions — including New York University, Columbia University, Brigham & Women's Hospital at Harvard Medical School, and the University of Southern California Keck School of Medicine — and earned both an MBA and MS from Cornell.
His clinical practice centres on interventional endoscopy and endobariatrics: minimally invasive procedures for obesity, gastrointestinal cancers, and complex pancreaticobiliary disease. Today, Dr. Sachdev attends to a deliberately small, discerning clientele from private consulting rooms in Manhattan and Beverly Hills, accepting new patients exclusively through referral.
In 2019, he was invited to serve at the White House and the U.S. Department of Health & Human Services, contributing to the federal COVID-19 response with a particular focus on healthcare delivery in rural America and the expansion of telehealth access.
Medicine at its highest expression is a conversation — between physician and patient, between data and intuition, between what we know and what we are still discovering.— Dr. Amit H. Sachdev
Dr. Sachdev's scientific formation began at The Rockefeller University, in the laboratory of Günter Blobel.
Recipient of the 1999 Nobel Prize in Physiology or Medicine for the discovery of the signal peptides that govern protein trafficking within the cell.
Minimally invasive endoscopic procedures for weight loss — endoscopic sleeve gastroplasty, intragastric balloon placement, and the management of weight regain following bariatric surgery.
Endoscopic submucosal dissection, mucosal resection, endoscopic ultrasound, and ERCP for the diagnosis and treatment of early gastrointestinal cancers and complex pancreaticobiliary disease.
Discreet, comprehensive care for reflux disease, inflammatory bowel disease, irritable bowel syndrome, esophageal and duodenal disorders, and colorectal cancer screening.
Evidence-based management of IBS, SIBO, functional dyspepsia, and the gut-brain axis — informed by years of research with Dr. Mark Pimentel at Cedars-Sinai.
Evaluation and management of fatty liver disease, NASH, cirrhosis, and the gastrointestinal complications of portal hypertension.
For patients abroad or in transit, virtual consultation extends the same standard of attention without compromise — informed by Dr. Sachdev's federal work on telehealth policy.
In 2019, Dr. Sachdev was invited to serve at the White House and the U.S. Department of Health and Human Services, contributing to the federal response to the COVID-19 pandemic.
His policy work focused on two of the country's most pressing healthcare challenges: improving care delivery in rural America, and expanding the reach of telehealth — a discipline that has since become central to how specialist medicine is practiced at distance.
That experience continues to shape his practice today. The finest medicine, he believes, is informed not only by what happens at the bedside, but by an understanding of how care is organised, financed, and delivered at scale.
Dr. Sachdev accepts a deliberately limited number of new patients each year, by personal introduction. For consultation, scholarship, or media, kindly direct inquiries to the appropriate consulting rooms below.